Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01013077 · ClinicalTrials.gov registry record · NA
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
A NA study of Dry Eye Syndrome, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01013077: Completed NA study of Dry Eye Syndrome, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
NCT01013077 is a NA study of Dry Eye Syndrome that has completed, run by Southern California College of Optometry at Marshall B. Ketchum University. The registered enrollment target is 20 participants, below the 163-participant average among 10 other Dry Eye Syndrome trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01013077, a NA study of Dry Eye Syndrome, has completed, sponsored by Southern California College of Optometry at Marshall B. Ketchum University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate how the addition of a new emulsion artificial tear to the tear layer of dry eye and normal patients affects aberrometry, contrast sensitivity, and reading ability over time. Previous studies have indicated that daily use of artificial tears over a two week period decreases the short term affect of drop application on aberrometry and contrast sensitivity measurements. The present study will examine the effects of 4 weeks of artificial tear use to determine when the responses stabilize.
Primary Outcome
Change in contrast sensitivity with administration of the artificial tear. During a visit, contrast sensitivity is initially monitored for several minutes (i.e., pre-artificial tear application contrast sensitivity) and the artificial tear is then applied and the contrast sensitivity is continually measured for several more minutes (post-artificial tear application contrast sensitivity). The administration of the artificial tear decreases contrast sensitivity for approximately a minute. The data
Conditions Studied
Interventions
- OTHER Optive, Soothe, New Emulsion
- OTHER Soothe, New Emulsion, Optive
- OTHER New Emulsion, Optive, Soothe
Study Locations (1)
California
- Southern California College of Optometry - Fullerton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT01013077 record still lists
NCT01013077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 163-participant average among 10 other Dry Eye Syndrome trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Dry Eye Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Optive, Soothe, New Emulsion is the first listed.
NCT01013077 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01013077 about?
NCT01013077 is a clinical study titled "The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability". The purpose of this study is to investigate how the addition of a new emulsion artificial tear to the tear layer of dry eye and normal patients affects aberrometry, contrast sensitivity, and reading ability over time. Previous studies have indicated that daily use of artificial tears over a two week...
What is the current status of trial NCT01013077?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-11. Estimated completion is 2011-08.
What conditions does trial NCT01013077 study?
This clinical trial studies the following conditions: Dry Eye Syndrome.
What interventions are being tested in trial NCT01013077?
The interventions under investigation include: Optive, Soothe, New Emulsion (OTHER), Soothe, New Emulsion, Optive (OTHER), New Emulsion, Optive, Soothe (OTHER).
Who is sponsoring clinical trial NCT01013077?
This trial is sponsored by Southern California College of Optometry at Marshall B. Ketchum University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01013077 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01013077's enrollment target sits among peer trials
20 10th of 10 the lowest of 10 other Dry Eye Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Omega-3 Fatty Acids in the Treatment of Dry Eye Syndrome
COMPLETED · NA
-
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
COMPLETED · NA
-
A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)
RECRUITING · Phase 1
-
Study of SkQ1 as Treatment for Dry-eye Syndrome
COMPLETED · Phase 3
-
Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Dry Eye
COMPLETED · Phase 2
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia